MEGAN ZINO: Open Payments
NPI 1144819186 · RICHBORO, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 10 payments from 7 companies in 2025. Trend: 2023 $494 · 2024 $486 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $58 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| GENZYME CORPORATION | 1 | $29 |
| Janssen Biotech, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $14 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: DUPIXENT, Bimzelx, ILUMYA, TREMFYA, RINVOQ, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
